v3.26.3
CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Nov. 30, 2024   75,870,718      
Beginning balance at Nov. 30, 2024 $ 526,993 $ 76 $ 1,265,536 $ 150 $ (738,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   37,428      
Exercise of stock options 221   221    
Vesting of restricted stock units (in shares)   242,923      
Issuance of common stock under employee stock purchase plan (in shares)   83,730      
Issuance of common stock under employee stock purchase plan 1,252   1,252    
Stock-based compensation 8,726   8,726    
Unrealized gain (loss) on available-for-sale marketable securities 76     76  
Net income (loss) (56,351)       (56,351)
Ending balance (in shares) at Feb. 28, 2025   76,234,799      
Ending balance at Feb. 28, 2025 480,917 $ 76 1,275,735 226 (795,120)
Beginning balance (in shares) at Nov. 30, 2024   75,870,718      
Beginning balance at Nov. 30, 2024 526,993 $ 76 1,265,536 150 (738,769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized gain (loss) on available-for-sale marketable securities (31)        
Net income (loss) (186,236)        
Ending balance (in shares) at Aug. 31, 2025   76,872,686      
Ending balance at Aug. 31, 2025 372,252 $ 77 1,297,061 119 (925,005)
Beginning balance (in shares) at Feb. 28, 2025   76,234,799      
Beginning balance at Feb. 28, 2025 480,917 $ 76 1,275,735 226 (795,120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,233      
Exercise of stock options 6   6    
Vesting of restricted stock units (in shares)   197,632      
Stock-based compensation 10,390   10,390    
Unrealized gain (loss) on available-for-sale marketable securities (246)     (246)  
Net income (loss) (43,464)       (43,464)
Ending balance (in shares) at May. 31, 2025   76,433,664      
Ending balance at May. 31, 2025 447,603 $ 76 1,286,131 (20) (838,584)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   18,822      
Exercise of stock options 178 $ 1 177    
Vesting of restricted stock units (in shares)   311,485      
Issuance of common stock under employee stock purchase plan (in shares)   108,715      
Issuance of common stock under employee stock purchase plan 977   977    
Stock-based compensation 9,776   9,776    
Unrealized gain (loss) on available-for-sale marketable securities 139     139  
Net income (loss) (86,421)       (86,421)
Ending balance (in shares) at Aug. 31, 2025   76,872,686      
Ending balance at Aug. 31, 2025 372,252 $ 77 1,297,061 119 (925,005)
Beginning balance (in shares) at Nov. 30, 2025   101,807,484      
Beginning balance at Nov. 30, 2025 538,747 $ 102 1,541,766 105 (1,003,226)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in “at the market” financing, net of issuance costs (in shares)   1,000,000      
Issuance of common stock in “at the market” financing, net of issuance costs 17,994 $ 1 17,993    
Exercise of stock options (in shares)   77,942      
Exercise of stock options 375   375    
Vesting of restricted stock units (in shares)   330,395      
Issuance of common stock under employee stock purchase plan (in shares)   183,992      
Issuance of common stock under employee stock purchase plan 1,596   1,596    
Stock-based compensation 9,404   9,404    
Unrealized gain (loss) on available-for-sale marketable securities (49)     (49)  
Net income (loss) (87,174)       (87,174)
Ending balance (in shares) at Feb. 28, 2026   103,399,813      
Ending balance at Feb. 28, 2026 480,893 $ 103 1,571,134 56 (1,090,400)
Beginning balance (in shares) at Nov. 30, 2025   101,807,484      
Beginning balance at Nov. 30, 2025 538,747 $ 102 1,541,766 105 (1,003,226)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Unrealized gain (loss) on available-for-sale marketable securities (315)        
Net income (loss) 373,098        
Ending balance (in shares) at Aug. 31, 2026   109,200,394      
Ending balance at Aug. 31, 2026 968,311 $ 109 1,598,540 (210) (630,128)
Beginning balance (in shares) at Feb. 28, 2026   103,399,813      
Beginning balance at Feb. 28, 2026 480,893 $ 103 1,571,134 56 (1,090,400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   6,688      
Exercise of stock options 66   66    
Vesting of restricted stock units (in shares)   295,010      
Vesting of restricted stock units 0 $ 1 (1)    
Stock-based compensation 11,404   11,404    
Unrealized gain (loss) on available-for-sale marketable securities (201)     (201)  
Net income (loss) (89,535)       (89,535)
Ending balance (in shares) at May. 31, 2026   103,701,511      
Ending balance at May. 31, 2026 402,627 $ 104 1,582,603 (145) (1,179,935)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of pre-funded warrants (in shares)   4,708,290      
Exercise of pre-funded warrants 0 $ 5 (5)    
Exercise of stock options (in shares)   363,266      
Exercise of stock options 4,020   4,020    
Vesting of restricted stock units (in shares)   341,632      
Issuance of common stock under employee stock purchase plan (in shares)   85,695      
Issuance of common stock under employee stock purchase plan 1,139   1,139    
Stock-based compensation 10,783   10,783    
Unrealized gain (loss) on available-for-sale marketable securities (65)     (65)  
Net income (loss) 549,807       549,807
Ending balance (in shares) at Aug. 31, 2026   109,200,394      
Ending balance at Aug. 31, 2026 $ 968,311 $ 109 $ 1,598,540 $ (210) $ (630,128)